Table: Hisamitsu - 6-MTH group results
Oct 8 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Aug 31, 2020 Aug 31, 2019 Feb 28, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 52.93 63.40 127.00
(-16.5 pct) (-8.6 pct) (-9.9 pct)
Operating 5.52 10.19 12.90
(-45.9 pct) (-9.4 pct) (-43.2 pct)
Recurring 5.52 10.64 14.80
(-48.1 pct) (-11.4 pct) (-42.3 pct)
Net 3.69 7.55 10.60
(-51.1 pct) (-17.6 pct) (-43.3 pct)
EPS 45.22 yen 91.37 yen 129.77 yen
EPS Diluted 45.16 yen 91.27 yen
Ann Div 83.00 yen 83.50 yen
-Q2 div 41.75 yen 41.50 yen
-Q4 div 41.50 yen 41.75 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO